Stock listing

NASDAQ:ADAG Adagene, Inc. Stock

Follow Adagene, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:ADAG

$2.06 USD -0.34 (-14.2%)

Close on Oct 16, 2026

Ticker: NASDAQ:ADAG
Asset type: Stock
Exchange: NASDAQ
Currency: USD

What changed lately

Latest news release · Apr 2, 2026
Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte’s TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable Colorectal Cancer (MSS CRC)
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 34 slides

Latest news

Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte’s TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable Colorectal Cancer (MSS CRC)

Apr 2, 2026

All Adagene, Inc. news

Decks

Investor Presentation (September 2026)
Investor deck · 34 slides · September 2026
Investor Presentation (July 2023)
Investor deck · 31 slides · Jul 7, 2023
Investor Presentation (January 2022)
Investor deck · 19 slides · Jan 12, 2022

Adagene, Inc. on 6ix

News releases: 1 in the last 12 months · 1 in all · newest Apr 2, 2026 · oldest 2026
Decks: 3 decks · latest September 2026

Log in to ask 6ix AI your own questions about Adagene, Inc.